| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c9fe105d10b1b038e3a67bbc4839c1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_782cdc7f0509d45f1deda05f5db461d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_396ad59837f77ecd17fd0c585bbd014c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34 |
| filingDate |
2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_212e04ab991a76be49740fe817d67ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_032a2ce2300e1089b85651aaf048ef60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5adbde02cc97b9c8e67ebab1bbf3c47 |
| publicationDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0051632-A2 |
| titleOfInvention |
COPPER AGONIST THAT BINDS ON THE COPPER BINDING SITE OF APP AND/OR EXERTS AN INHIBITING EFFECT ON THE RELEASE OF AMYLOID Aβ PEPTIDE |
| abstract |
The invention relates to copper agonists that bind on the copper binding site of APP and/or exert an inhibiting effect on the release of the amyloid A beta peptide participating in the emergence of Alzheimer's disease. The invention also relates to the drugs containing said copper agonists or to the utilization of said copper agonists for the preparation of a drug for the prevention and/or treatment of Alzheimer's disease. The invention further relates to a method for identifying copper agonists having the desired effect described in the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0150127-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0150127-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8894999-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6696263-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248898-A1 |
| priorityDate |
1999-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |